Cécile Dupont Redon

Cécile Dupont Redon serves as the Chief Executive Officer at BrightHeart since November 2022 and is a Partner and previously held multiple roles including Principal and Senior Associate at Sofinnova Partners since July 2019, an independent venture capital firm in Paris focused on early-stage Life Sciences companies. In addition, Cécile holds a board member position at Endoron Medical, contributing to the development of a novel catheter-based endograft solution, and serves as President of HEPTA Medical. Cécile's experience includes senior roles at Gradient Denervation Technologies, MD Start, SafeHeal, DAMAE Medical, BD, and Mauna Kea Technologies. Cécile holds a biomedical degree from Université de Technologie de Compiègne and has completed a corporate finance program at HEC Paris, along with various studies in international settings.